Milestone Scientific announced a strategic partnership with Axial Biologics, a medical device company with a vast distribution network. Under the agreement, Axial Biologics will serve as the distributor of Milestone Scientific’s CompuFlo Epidural System in New Jersey, Texas, and Florida. This partnership immediately follows the recent announcements that the company has been granted a Medicare Part B Physician payment rate for the CompuFlo Epidural System under the American Medical Association’s technology-specific Category III CPT code CPT0777T by Novitas Solutions and First Coast Service Options, the Jurisdictional Medicare Administrative Contractors in New Jersey, Texas and Florida. The Medicare Price Assignment marks a significant milestone for the CompuFlo technology, enabling broader access and adoption within the pain management community, particularly for Medicare patients.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MLSS:
- Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and Florida
- Milestone Scientific Secures Key Patent Approvals in the U.S. and Europe
- Milestone Scientific announces receipt of multiple NOAs for patent applications
- Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and Delaware
- Milestone Scientific announces Medicare price assignment for CompuFlo
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue